Incidence and Survival by Human Epidermal Growth Factor Receptor-2 Status in Young Women with Stage I-III Breast Cancer: SEER 2010–2016

BACKGROUND: Young, premenopausal women with breast cancer often experience more aggressive disease biology and poorer survival than older women. Diagnostic and therapeutic advances, including human epidermal growth factor receptor-2 (HER2)-directed therapy, may lessen treatment burden and improve su...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Breast Cancer
Main Authors: Thomas, Alexandra, Rhoads, Anthony, Suhl, Jonathan, Conway, Kristin M, Hundley, William G, McNally, Lacey R, Oleson, Jacob, Melin, Susan A, Lynch, Charles F, Romitti, Paul A
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7398833/
https://ncbi.nlm.nih.gov/pubmed/32278642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clbc.2020.01.014
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados